Use access key #2 to skip to page content.
$50.99 -1.30 (-2.49%)
10/6/2008 9:57 AM

Novo Nordisk A/S (ADR) (NVO)

CAPS Rating:
****

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

View All Commentary (NVO)

Recs

0

Avatar hansthered0 (< 20) Submitted: 6/15/08 1:13 PM : Outperform Start Price: $67.49 NVO Score: -1.69

Magic Scouter

Report this Post Replies: 0 | Reply

Featured Broker Partners